ABPI Logo
  • Developing medicines
    • Responding to COVID-19
    • Clinical trials and research
    • Building a thriving environment for medicine discovery
    • UK-EU Future Relationship
    • Life Sciences Industrial Strategy
    • ABPI Medical Representatives Exam
  • Accessing medicines
    • How medicines are priced in the UK
    • Working with the NHS
    • Supply chain
    • Antimicrobial resistance (AMR)
    • Vaccines
    • What is the NICE Methods Review?
    • Rare diseases: Facing three challenges
  • Our ethics
    • ABPI Code of Practice
    • Disclosure UK
    • Appropriate prescribing
    • Patient & public involvement
  • Member representation
    • Events
    • Full membership
    • Working with our members​
    • ABPI Members List
    • Membership benefits
  • Who We Are
  • Media
  • Publications
  • Facts and Figures
  • Contact Us
MY ABPI LOGIN
 
  • The Association of the British Pharmaceutical Industry
  • Accessing medicines
  • Supply chain
  • Managing medicine shortages

Managing medicine shortages

Every day millions of patients rely on medicines supplied by the pharmaceutical industry.

Manufacturers know that any medicine shortage is extremely worrying for the people affected by it. They do everything they can to prevent medicine supply problems occurring and to resolve them quickly if they do happen. 

Companies work to prevent shortages happening in the first place in a number of ways:

  • Each part of the manufacturing and distribution process is risk assessed and back-up plans are put in place  
  • Preventative maintenance work is done on production machinery 
  • Companies review usage levels to predict seasonal spikes in demand and query unusual order patterns
  • Stock levels are monitored and managed and stock may be reallocated from one market to another if needed

Despite the best efforts of all concerned, supply problems can happen for unforeseen reasons such as:

  • Manufacturing problems 
  • Availability of raw materials (active pharmaceutical ingredients), or other medicine or pack components 
  • Unexpected demand

Government reporting requirements for medicines shortages and discontinuations

If shortages arise, companies are required to notify the Department of Health and Social Care (DHSC) who will work with a range of stakeholders to resolve them quickly using tried and tested procedures.

The DHSC has now published guidance which outlines the obligations on companies to inform the department of any medicine discontinuations or anticipated supply shortages, to help manage supply issues and mitigate any potential impacts on patients.

Companies take their responsibilities very seriously and are accountable to UK regulators should supplies of their products become unavailable.

Winter flu vaccine supply 2020

To help answer questions you may be getting on flu vaccine availability, the Department of Health and Social Care has created a new two-page leaflet. It explains that there is sufficient vaccine available for all eligible groups. It also highlights why a person who is eligible may be asked to wait for a vaccine while reassuring them they will be able to have one before flu season starts. Read more here. 

The ABPI's Rick Greville also talks about winter flu supply in his evidence session to the Welsh Parliament below.

Supply chain

  • Falsified Medicines Directive (FMD)
  • Managing medicine shortages
  • Counterfeiting

ABPI

The Association of the British Pharmaceutical Industry is a company limited by guarantee registered in England and Wales 
(registered number 09826787) and its registered office is at 7th Floor Southside,105 Victoria Street, London, SW1E 6QT.
Telephone +44 (0) 207 9303477

© ABPI 2021
  • Twitter Logo
  • LinkedIn
  • YouTube Logo

Devolved Nations

  • Cymru Wales
  • Northern Ireland
  • Scotland

Quick Links

  • ABPI Exam
  • Disclosure UK
  • Frequently Asked Questions
  • Careers
  • Schools
  • Acronym buster

Website Info

  • Terms and conditions
  • Accessibility
  • Cookie Policy

Prescription Medicines Code of Practice Authority (PMCPA)

The Prescription Medicines Code of Practice Authority (PMCPA) was established by The Association of the British Pharmaceutical Industry to operate the ABPI Code of Practice for the Pharmaceutical Industry independently of the ABPI. The PMCPA is a division of ABPI which is a company registered in England and Wales (registered number 09826787) with its registered office at 7th Floor, Southside, 105 Victoria Street, London SW1E 6QT.

Office of Health Economics (OHE)

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 7th Floor Southside, 105 Victoria Street, London, SW1E 6QT. OHE provides independent research, advisory and consultancy services on policy implications and economic issues within the pharmaceutical, health care and biotechnology sectors.